Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.

Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.

Africa-focused e-commerce company Jumia floated in the middle of its range, with more than half the shares being bought by existing corporate investors.

The biopharmaceutical developer floated at the top of its range and will secure $65.9m from existing backer Merck & Co through a private placement.

Alibaba-backed social influencer network Ruhnn floated in the middle of its range in the US, with Weibo buying $8m of shares.

The Baxter and Amgen-backed genome editing technology developer floated in the middle of its range and is now valued at more than $780m.

The Xiaomi-backed online brokerage floated above its range while its other corporate investor, International Brokers, bought more than $13m of shares.

Abiomed-backed Shockwave Medical has raised approximately $97m in an oversubscribed initial public offering, before its shares climbed more than 85% by the end of Friday.

Tencent invested $8m as the Chinese online brokerage floated at the top of its range in the US, at a valuation of more than $1.3bn.

Genomic medicine developer Precision Biosciences plans to raise up to $100m in an upcoming IPO that could hand exits to Duke University and corporates Amgen, EMS and Baxter.